Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Perfusion pressure targets and tissue perfusion in septic shock
2006-005253-30Phase 4Terminated
- Sponsor
- Queen Mary University of London
- Start
- Oct 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of norepinephrine in septic shock (2 arms), sponsored by Queen Mary University of London. Primary endpoints: Effect of different mean arterial pressure targets on microvascular flow and Effect of mean arterial pressure targets on tissue oxygenation. Started Oct 2006; status: terminated.
02
Drugs
norepinephrine
03
Conditions
septic shock
Beyond the preview
Go deeper on 2006-005253-30.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-005253-30.